The newly launched Cortellis Drugs to Watch 2020 list identifies eleven drugs that are set to enter the market in 2020 and reach more than $1 billion in sales by 2024. Therapies targeting central nervous system indications and cancer dominate the list. The list highlights yet another strong showing by orphan drug status or other designations, as well. Great majority of the medicines are for indications crowded with competitors. Thus, there will be substantial pressure on these therapeutics to differentiate from existing products. We will also discuss the latest development on COVID-19 and what we know so far.
1. Which are the new potential blockbuster drugs to be launched this year?
2. What are the disease areas that they will be focusing on?
3. Which drugs will these potential blockbusters be competing with?
4. What is the latest progress with COVID-19 treatment development?